Aerobic Capacity and Body Composition in Colon Cancer Patients
Completed
- Conditions
- First Posted Date
- 2007-05-08
- Last Posted Date
- 2016-02-26
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 40
- Registration Number
- NCT00470782
- Locations
- ๐จ๐ฆ
Cross Cancer Institute, Edmonton, Alberta, Canada
Tomotherapy Treatment for Mesothelioma
Phase 2
Completed
- Conditions
- First Posted Date
- 2007-05-04
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 18
- Registration Number
- NCT00469196
- Locations
- ๐จ๐ฆ
Cross Cancer Institute, Edmonton, Alberta, Canada
Hypofractionated Radiotherapy for Small Cell Lung Cancer
Phase 1
Completed
- Conditions
- First Posted Date
- 2007-05-04
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 24
- Registration Number
- NCT00469222
- Locations
- ๐จ๐ฆ
Cross Cancer Institute, Edmonton, Alberta, Canada
Cone Beam CT Scanning in Lung and Bladder Cancer.
Completed
- Conditions
- First Posted Date
- 2007-05-04
- Last Posted Date
- 2016-02-24
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 22
- Registration Number
- NCT00469066
- Locations
- ๐จ๐ฆ
Cross Cancer Institute, Edmonton, Alberta, Canada
The Feasibility of Physical Activity in Advanced Cancer Patients
Completed
- Conditions
- First Posted Date
- 2007-02-22
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 30
- Registration Number
- NCT00438620
- Locations
- ๐จ๐ฆ
Cross Cancer Institute, Edmonton, Alberta, Canada
Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL
Phase 2
Withdrawn
- Conditions
- First Posted Date
- 2006-12-21
- Last Posted Date
- 2016-02-15
- Lead Sponsor
- AHS Cancer Control Alberta
- Registration Number
- NCT00414089
- Locations
- ๐จ๐ฆ
Cross Cancer Institute, Edmonton, Alberta, Canada
An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs
- First Posted Date
- 2006-12-21
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 11
- Registration Number
- NCT00414570
- Locations
- ๐จ๐ฆ
Cross Cancer Institute, Edmonton, Alberta, Canada
The Utility of FDG-PET for Radiation Treatment in NSCLC
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2017-07-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 50
- Registration Number
- NCT00385164
- Locations
- ๐จ๐ฆ
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/Chemotherapy
Completed
- Conditions
- First Posted Date
- 2006-09-13
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 100
- Registration Number
- NCT00375921
- Locations
- ๐จ๐ฆ
Cross Cancer Institute, Edmonton, Alberta, Canada
Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy
Not Applicable
Withdrawn
- Conditions
- First Posted Date
- 2006-09-13
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Registration Number
- NCT00375700
ยฉ Copyright 2024. All Rights Reserved by MedPath